Lucy Meunier
Overview
Explore the profile of Lucy Meunier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lallement A, Lamoureux A, Hummelsberger M, Maria A, Meunier L
Clin Res Hepatol Gastroenterol
. 2023 Aug;
47(8):102192.
PMID: 37567465
We report the case of a 63-year-old patient with recurrence of acral malignant melanoma after adjuvant immune checkpoint inhibitors (ICI) treatment by PEMBROLIZUMAB complicated with immune-related grade II hepatitis. Rechallenge...
12.
Hountondji L, Ferreira De Matos C, Lebosse F, Quantin X, Lesage C, Palassin P, et al.
JHEP Rep
. 2023 May;
5(6):100719.
PMID: 37138674
Background & Aims: Immune checkpoint inhibitors (ICIs) have changed the landscape of cancer therapy. Liver toxicity occurs in up to 25% of patients treated with ICIs. The aim of our...
13.
14.
Meunier L, Belkacemi M, Pageaux G, Radenne S, Vallet-Pichard A, Houssel-Debry P, et al.
Viruses
. 2023 Jan;
15(1).
PMID: 36680177
Background: Direct-acting antiviral (DAA) agents for the treatment of hepatitis C virus (HCV) infection have been proven safe and effective in cirrhotic patients awaiting liver transplantation (LT). However, in the...
15.
Thabut D, Bouzbib C, Meunier L, Haas M, Weiss N, Louvet A, et al.
Liver Int
. 2023 Jan;
43(4):750-762.
PMID: 36625084
Hepatic encephalopathy (HE) is a frequent and severe complication of liver disease with poor patient outcomes. However, it is a poorly understood complication, with no consensus for diagnosis. Therefore, HE...
16.
Meunier L, Larrey D
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36614299
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system and the association with other autoimmune diseases is well-documented. There are many therapeutic options for the treatment...
17.
Meunier L, Malezieux E, Bedoya J, Faure S, Echenne M, Debourdeau A, et al.
Liver Transpl
. 2022 Sep;
29(1):114-117.
PMID: 36047916
No abstract available.
18.
Artzner T, Conti S, Cortesi P, Sacleux S, Fernandez J, Morelli M, et al.
Liver Transpl
. 2022 May;
28(9):1429-1440.
PMID: 35544360
There is growing evidence that liver transplantation (LT) is the most effective treatment for acute-on-chronic liver failure grade-3 (ACLF-3). This study examines whether and how this evidence translates into practice...
19.
Ursic-Bedoya J, Chavey C, Desandre G, Meunier L, Dupuy A, Gonzalez-Dopeso Reyes I, et al.
Mol Metab
. 2022 Apr;
60:101483.
PMID: 35367668
Fibroblast growth factor 19 (FGF19) is a hormone with pleiotropic metabolic functions, leading to ongoing development of analogues for treatment of metabolic disorders. On the other hand, FGF19 is overexpressed...
20.
Meunier L, Sanavio M, Dumortier J, Meszaros M, Faure S, Bedoya J, et al.
Liver Int
. 2022 Mar;
42(8):1872-1878.
PMID: 35338550
Background And Aims: After 2 doses, the efficacy of anti-SARS-CoV-2 vaccination seems to be lower in solid organ transplant recipients than in the immunocompetent population. The objective of this study...